RARA CRAFT DATABASE for FDA Medical Devices
510(k)K212243

FDA DEVICE FACTS

VITEK 2 AST- Gram Positive Telavancin (<=0.015 - >=1 µg/mL)

bioMerieux, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEAugust 8, 2022PRODUCT CODELON

Indications for use

VITEK8 2 AST-Granm Positive Telavancin is designed for antimicrobial susceptibility testing of Gram positive microorganisms and is intended for use with the VITEK® 2 and VITEK* 2 Compact Systems as a laboratory aid in the detennination of in vitro susceptibility to antimicrobial agents. VITEK® 2 AST-Grain Positive Telavancin is a quantitative test. Telavancin has been shown to be active against most strains of the microorganisms listed below. according to the FDA label for this antimicrobial. Active both in vitro and in clinical infections Staphlococcus aureis (including nethicillin-resistant isolates) Enterococcusfaecalis (vancomycin-susceptible isolates only) The VITEK® 2 Gram-positive Susceptibility Card is intended for use with the VITEK® 2 Systems in clinical laboratories as an in vitro test to detennine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents when used as instructed.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 22, 2026